Sudair Pharma concluded a remarkable participation at the Global Health Exhibition 2025, one of the region’s most prominent healthcare events, attracting leaders, experts, and innovators from across the industry.
Throughout the exhibition, the Sudair Pharma booth became a key destination for visitors seeking to learn about the company’s progress in localizing pharmaceutical manufacturing, developing advanced drug technologies, and supporting national healthcare transformation.
The SPC team engaged in high-level discussions with healthcare leaders, regulatory bodies, and strategic partners. These exchanges highlighted the company’s commitment to expanding local production of essential and specialized medicines, fostering innovation, and contributing to Saudi Arabia’s long-term healthcare objectives.
The exhibition also provided an opportunity to showcase Sudair Pharma’s achievements in oncology, insulin technologies, sterile manufacturing, and biopharmaceutical capabilities — representing a strong model for national industrial advancement.
Sudair Pharma continues to reinforce its role as a leading pharmaceutical manufacturer in the Kingdom, aligned with Vision 2030 and dedicated to building a healthier and more sustainable future for patients.
